Observed Side Effects (From Clinical Trials) In the Lancet 2021 Phase 2 trial (n=706), at the highest 4.5 mg/week dose, 88% of participants reported at least one side effect and 63% reported a GI-specific event
Together, these functions can help reduce hunger, slow gastric emptying and treat insulin resistance allowing you to lose weight
Retatrutide is injected subcutaneously once weekly, on the same day each week, with or without meals
Without the basic support layers (poor sleep, not enough hydration, lack of protein, low vitamin C levels), no amount of KLOW will achieve the desired effects
Sexual health: Youll detail your sexual health concerns, such as birth control needs or performance issues